CORTESE, ROSA
 Distribuzione geografica
Continente #
EU - Europa 2.490
NA - Nord America 2.081
AS - Asia 1.696
SA - Sud America 431
Continente sconosciuto - Info sul continente non disponibili 183
AF - Africa 118
OC - Oceania 5
Totale 7.004
Nazione #
US - Stati Uniti d'America 2.021
IT - Italia 904
SG - Singapore 594
RU - Federazione Russa 506
CN - Cina 403
BR - Brasile 356
IE - Irlanda 324
VN - Vietnam 170
HK - Hong Kong 164
GB - Regno Unito 152
FR - Francia 130
SE - Svezia 120
KR - Corea 93
DE - Germania 90
ZA - Sudafrica 72
FI - Finlandia 67
IN - India 67
BD - Bangladesh 61
ES - Italia 61
NL - Olanda 52
CA - Canada 34
AR - Argentina 22
TR - Turchia 22
IQ - Iraq 18
PL - Polonia 16
IR - Iran 14
KE - Kenya 14
AT - Austria 13
CH - Svizzera 13
EC - Ecuador 12
ID - Indonesia 12
PK - Pakistan 12
MX - Messico 11
UA - Ucraina 11
CO - Colombia 10
JP - Giappone 10
SA - Arabia Saudita 10
CL - Cile 9
CI - Costa d'Avorio 7
TN - Tunisia 7
UZ - Uzbekistan 7
HU - Ungheria 6
VE - Venezuela 6
BE - Belgio 5
JO - Giordania 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
AU - Australia 4
BO - Bolivia 4
LT - Lituania 4
NG - Nigeria 4
PH - Filippine 4
AL - Albania 3
DZ - Algeria 3
EG - Egitto 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
LB - Libano 3
MN - Mongolia 3
OM - Oman 3
SY - Repubblica araba siriana 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
GR - Grecia 2
IL - Israele 2
KH - Cambogia 2
MY - Malesia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CR - Costa Rica 1
CU - Cuba 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 6.822
Città #
Dallas 332
Dublin 300
Singapore 289
Santa Clara 249
San Jose 207
Milan 182
Ashburn 178
Hong Kong 153
Hefei 142
Moscow 135
Council Bluffs 132
Southend 95
Seoul 92
Beijing 86
Siena 84
Rome 71
Johannesburg 63
Ho Chi Minh City 62
Los Angeles 62
Chandler 49
Málaga 44
Helsinki 41
Lauterbourg 40
Columbus 39
New York 38
Florence 36
Hanoi 36
São Paulo 34
Munich 31
Princeton 31
Buffalo 28
Fairfield 23
Bengaluru 22
Houston 17
Naples 17
Phoenix 17
Chicago 16
Pisa 16
San Francisco 16
Turin 16
Lappeenranta 15
The Dalles 15
Frankfurt am Main 14
Redondo Beach 14
Cambridge 13
Nuremberg 13
Seattle 13
Belo Horizonte 12
Boston 12
Sarzana 12
Warsaw 12
Wilmington 12
Bari 11
Genoa 11
Livorno 11
London 11
Lucca 11
Montreal 11
Reggio Emilia 11
Chennai 10
Haiphong 10
Manchester 10
Salvador 10
Woodbridge 10
Amsterdam 9
Baghdad 9
Orem 9
Rio de Janeiro 9
Atlanta 8
Bologna 8
Carlentini 8
Fremont 8
Porto Alegre 8
Tokyo 8
Turku 8
Abidjan 7
Dhaka 7
Dong Ket 7
Figino 7
Hải Dương 7
Shanghai 7
Tashkent 7
Verona 7
Boardman 6
Brasília 6
Brooklyn 6
Campinas 6
Denver 6
Des Moines 6
Hangzhou 6
Modena 6
Newark 6
Padua 6
Pescara 6
Sacramento 6
Salt Lake City 6
San Diego 6
Tehran 6
Amman 5
Brescia 5
Totale 4.053
Nome #
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study 311
The brief repeatable battery of neuropsychological tests (BRB-N) version a: update of Italian normative data from the Italian Neuroimaging Network Initiative (INNI) 264
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 225
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 206
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations 195
Hippocampal atrophy and white matter lesions characteristics can predict evolution to dementia in patients with vascular mild cognitive impairment 188
Regional hippocampal atrophy reflects memory impairment in patients with early relapsing remitting multiple sclerosis 182
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 171
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 150
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 149
Uveitis: A snapshot in the MOG antibody spectrum 146
MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease 143
Establishment of a clinician-led guideline on the diagnosis and treatment of Hirayama disease using a modified Delphi technique 141
FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years 140
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 137
Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis 136
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis 133
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 132
Prevalence of chronic comorbidities in people with multiple sclerosis: descriptive study based on administrative data in Tuscany (Central Italy) 132
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging 131
BIANCA-MS: An optimized tool for automated multiple sclerosis lesion segmentation 126
Cerebrospinal fluid neurofilament light chain levels: Marker of progression to generalized amyotrophic lateral sclerosis 122
Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD 122
Clinical course of central nervous system demyelinating neurological adverse events associated with anti-TNF therapy 121
Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis 119
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique 119
Gender Inequities in the Multiple Sclerosis Community: A Call for Action 119
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 117
Editorial: Cognition in Multiple Sclerosis 114
Assessing Lumbar Plexus and Sciatic Nerve Damage in Relapsing-Remitting Multiple Sclerosis Using Magnetisation Transfer Ratio 113
Magnetic resonance imaging evidence supporting the efficacy of cladribine tablets in the treatment of relapsing-remitting multiple sclerosis 111
Vessel-CAPTCHA: An efficient learning framework for vessel annotation and segmentation 111
Evaluation of cervical spinal cord atrophy using a modified SIENA approach 110
High-dimensional detection of imaging response to treatment in multiple sclerosis 107
Fatigue in multiple sclerosis: The role of thalamus 107
Advances in brain imaging in multiple sclerosis 106
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 105
Author Correction: High-dimensional detection of imaging response to treatment in multiple sclerosis (npj Digital Medicine, (2019), 2, 1, (49), 10.1038/s41746-019-0127-8) 105
Structural and functional connectivity substrates of cognitive impairment in multiple sclerosis 103
Impact of 3 Tesla MRI on interobserver agreement in clinically isolated syndrome: A MAGNIMS multicentre study 103
Pregnancy and antibody-mediated CNS disorders: What do we know and what should we know? 98
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging – Yes 98
Time to generalisation as a predictor of prognosis in amyotrophic lateral sclerosis 98
Primary progressive multiple sclerosis presenting under the age of 18 years: Fact or fiction? 97
Ongoing microstructural changes in the cervical cord underpin disability progression in early primary progressive multiple sclerosis 97
Prediction of the information processing speed performance in multiple sclerosis using a machine learning approach in a large multicenter magnetic resonance imaging data set 89
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: A possible marker of disease severity and progression 83
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 77
Guiding differentiation of non-acute MOGAD from AQP4-NMOSD and RRMS using clinical and MRI measures 76
Amyotrophic lateral sclerosis: A new missense mutation in the SOD1 gene 70
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 66
Neurophysiological, imaging and neurobiological markers of central fatigue in multiple sclerosis 65
Gray matter MRI differentiates neuromyelitis optica from multiple sclerosis using random forest 52
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP) 49
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 41
Linking movement-related beta oscillations to cortical excitability, structural damage, and fatigue in multiple sclerosis 41
The role of imaging in Hirayama disease 32
Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal 29
Hirayama disease: the importance of an early diagnosis 28
Deep Learning Modeling to Differentiate Multiple Sclerosis From MOG Antibody–Associated Disease 23
Clinically Relevant Patterns of Co‐Fluctuating Structure and Function in Multiple Sclerosis 12
MRI in multiple sclerosis: progress in in-vivo pathobiology 11
Totale 7.004
Categoria #
all - tutte 27.191
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.191


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022223 0 1 3 2 3 6 2 1 83 9 52 61
2022/2023528 25 36 78 47 20 86 71 41 47 46 14 17
2023/2024453 12 14 37 18 10 109 175 13 6 12 5 42
2024/20251.653 47 67 145 95 211 83 83 107 145 95 171 404
2025/20263.669 303 460 352 410 549 87 381 133 136 246 281 331
2026/2027298 191 107 0 0 0 0 0 0 0 0 0 0
Totale 7.004